First Episode Psychosis Clinical Trial
Official title:
Reducing the Duration of Untreated Psychosis Through Community Education
The study examines the possible effect of a community campaign to decrease the duration of untreated psychosis in persons with their first episode of a psychotic disorder.
The study examines whether a community campaign can reduce over time the duration of untreated psychosis (DUP) among persons with first episode psychosis (FEP). The DUP of mental health patients with FEP who sought services at a public outpatient or an inpatient facility was assessed for a 15 month period prior to the campaign launch. This serves as the baseline or historical control. The DUP will continue to be assessed for another 3 years. The hypothesis being tested is that there will be a significant decrease in DUP between baseline, one-year, two-year and three-year follow-ups. This study is being carried out with Latinos in Los Angeles County because as a group, particularly among Spanish-speaking immigrants, Latinos are at high risk for prolonged DUP. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Completed |
NCT00202280 -
Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication
|
Phase 2/Phase 3 | |
Completed |
NCT01026584 -
Efficacy and Safety of Aripiprazole in First Episode Psychosis
|
Phase 4 | |
Completed |
NCT03983421 -
Feasibility of an Early Detection Program for Early Psychosis on a College Campus
|
||
Recruiting |
NCT04046497 -
Artificial Intelligence to Measure Adherence to Oral Medication
|
Phase 4 | |
Withdrawn |
NCT04369677 -
Thermoregulation Among Individuals With First-episode Psychosis
|
||
Completed |
NCT03568500 -
A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
|
Phase 4 | |
Completed |
NCT00916461 -
Role of Minocycline in First Episode Psychosis
|
Phase 1/Phase 2 | |
Recruiting |
NCT05310838 -
Optimizing Engagement in Services for First-Episode Psychosis
|
N/A | |
Completed |
NCT03501160 -
Socially Inappropriate Behaviour in People With First Episode Psychosis: A Caregivers' Perspective
|
||
Recruiting |
NCT03196128 -
Early Intervention Psychosis Communication and Engagement Trial
|
N/A | |
Recruiting |
NCT04005378 -
Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs
|
Phase 4 | |
Recruiting |
NCT03919760 -
Early Psychosis Intervention - Spreading Evidence-based Treatment
|
||
Completed |
NCT03409393 -
Feasibility and Relevance of High-Intensity Functional Training in Patients With First-Episode Psychosis
|
N/A | |
Completed |
NCT01753284 -
First Episode Psychosis and Pathway to Care in Nordland
|
||
Completed |
NCT01157585 -
Efficacy and Safety of Paliperidone ER in First Episode Psychosis
|
Phase 4 | |
Completed |
NCT05737966 -
Evaluation of Case Management for First Episode Psychosis Using the PEPsy-CM Checklist
|
||
Recruiting |
NCT04021719 -
OnTrackNY's Learning Healthcare System
|
||
Recruiting |
NCT04889911 -
Pilot RCT of Self-stigma Treatment for First Episode Psychosis
|
N/A | |
Recruiting |
NCT04853485 -
Repetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity Biotypes
|
N/A |